Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Paris
- Most recent report
- 6-K, filed Jul 2, 2026
- Filings on record
- 103 filings
- On EDGAR
- CIK 1956827
- Fiscal year ends
- December
- Filer status
- Accelerated filer Emerging growth company
Financials 8 of 38
- 6-K Report a foreign issuer made public elsewhere Jul 2, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 29, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 2, 2026
- 6-K Report a foreign issuer made public elsewhere May 22, 2026
- 6-K Report a foreign issuer made public elsewhere May 20, 2026
- 6-K Report a foreign issuer made public elsewhere May 7, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 20, 2026
- 20-F Annual report, foreign issuer Mar 23, 2026
Prospectuses and Registrations 8 of 14
- 424B5 Prospectus supplement for an offering Jul 2, 2026
- FWP Free writing prospectus Jul 1, 2026
- FWP Free writing prospectus Jun 30, 2026
- 424B5 Prospectus supplement for an offering Jun 30, 2026
- S-8 Registration statement for an employee plan Mar 23, 2026
- 424B5 Prospectus supplement for an offering Jul 24, 2025
- FWP Free writing prospectus Jul 24, 2025
- FWP Free writing prospectus Jul 23, 2025
Ownership 8 of 21
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 6, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended May 11, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 13, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jan 14, 2026
- 144 Notice of a proposed sale of restricted stock Jan 8, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 14, 2025
Other 8 of 30
Everything here comes from Abivax S.A.'s own filings on SEC EDGAR. The filing list is rechecked every hour.